L,-Between 1983 and 1988, a percutaneous trigeminal ganglion compression (PTGC) procedure for trigeminal neuralgia was performed on 22 patients. All patients were initially relieved of their pain. There were three recurrences (14%); two of these patients underwent a second PTGC procedure and one a partial trigeminal nerve root section. Follow-up examination 3 to 53 months after the procedure showed that all patients were free of pain. Morbidity included persistent minor hypesthesia in five patients, persistent minor dysesthesias in three, persistent minor weakness in three, aseptic meningitis in one, transient sixth nerve palsy in one, and transient otalgia in three. None of the patients had either anesthesia dolorosa or an absent corneal reflex.
p
ERCUTANEOUS trigeminal ganglion compression (PTGC) was introduced by Mullan in 1978 and its description was published in 1983. ~9 The present paper describes the results of PTGC in a series of 22 patients and summarizes the results of all other published PTGC studies. 1,2'5,7-9,18,] 9 The procedure is based on the technique of trigeminal ganglion compression performed by Shelden, et aL, 2z through a temporal craniotomy. In 1952, TaarnhCj 25 had reported on a series of patients treated by decompressing the posterior root rather than by sectioning it. A year later, Shelden, et aL, reported on 10 patients with trigeminal neuralgia treated by decompressing peripheral branches of the trigeminal nerve at the foramen ovale or rotundum, and concluded that the common success factor between these two procedures was operative trauma. Shelden, et aL, 2~ then treated 115 patients by subtemporal craniotomy and selective ganglion compression. All 115 patients were initially relieved of their pain, with a 14% to 20% recurrence rate. Morbidity included minimal to moderate sensory loss in 28%, dysesthesia in 12%, and "transient facial weakness" appearing on the 3rd and 4th postoperative day in 11%. There was one death from an intracerebral hematoma. In a series of 100 patients treated in 1963 by Graf, ~ using the Shelden operation, there was a 24% recurrence rate; 96% were initially relieved of their pain. Dysesthesias, unqualified by intensity, were described in 76% of patients. Graf did not observe evidence of motor root injury. No further reports of ganglion compression are available until Mullan modified the Shelden procedure to a percutaneous compression. 19
Clinical Material and Methods

Patient Population
Twenty-two patients, ranging in age from 36 to 83 years (mean 62 years), underwent 24 procedures. Sixteen patients were women. All had classic unilateral trigeminal neuralgia. Fourteen patients had pain on the fight side, and one suffered contralateral atypical facial pain. Primary hypertension was noted in four patients, atherosclerotic coronary disease in three, and multiple sclerosis in two. Eleven patients had previously undergone peripheral procedures for trigeminal neuralgia, including alcohol injection, radiofrequency rhizotomy, and peripheral neurectomy; most had been subjected to several different procedures. Two patients had previously received a posterior fossa microvascular decom-pression. Patients were considered for PTGC only after having failed recent medical management of their pain with carbamazepine and diphenylhydantoin, and often baclofen. Preoperative skull films, computerized tomography scans, or magnetic resonance images were routinely obtained. None of the patients had an associated arteriovenous malformation or tumor.
A PTGC procedure was performed for the following groups of patients: 1) elderly or medically infirm patients at greater risk for morbidity from a posterior fossa procedure; 2) young informed patients without a trigeminal deficit who sought a percutaneous procedure; and 3) patients who had previously undergone destructive procedures but who did not have major dysesthesias. Because PTGC caused weakness of the masseter muscle in 18% of patients in all published series, the procedure was not performed in patients with contralateral masseter or pterygoid weakness. The mean follow-up duration was 20 months (range 3 to 53 months).
Operative Technique
Modifications were made to the technique described by Mullan and Lichtor. 19 A trigeminal depressor response was noted during needle placement at the foramen ovale, catheter advancement, and balloon inflation. 3 After the 13th procedure, a temporary external pacemaker programmed to respond automatically if the heart rate dropped to below 45 beats]rain was used on each patient.* Atropine was given intravenously when the heart rate decreased below 45 beats]min during procedures in which the temporary pacemaker was not used.
All procedures were performed under general anesthesia in the operating room. Under intermittent monoplane fluoroscopic guidance, a No. 14 needle was positioned at the foramen ovate using standard H/irtel guidelines. 13 The needle did not penetrate beyond the foramen ovale. A No. 4 French Fogarty embolectomy catheter was then advanced 15 to 20 mm through the needle. The balloon was gradually inflated to 0.75 to 1.00 cc with 180 mg% iohexol, if possible, to achieve the pear shape recommended by Mullan and Lichtor. 19 The balloon remained inflated for between 1 and 3 minutes, then was deflated and removed. The inflation pressure of the No. 4 Fogarty catheter was measured in six patients by a Statham transducer connected to a polygraph.
Results
All 22 patients were initially relieved of their pain. There were three (14%) recurrences (after 8, 10, and 20 months); of these, two patients obtained pain relief with a second PTGC procedure and one underwent a posterior fossa approach with partial root section leading to complete pain relief. The mean duration of *Noninvasive temporary pacemaker, Model NTP-3003, manufactured by ZMI Corp., Cambridge, Massachusetts. * PTGC = percutaneous trigeminal ganglion compression.
patient hospitalization was 2 days (range 1 to 6 days). Follow-up examination (range 3 to 53 months, mean 20 months) revealed that all patients were pain-free. None of the patients had either an absent corneal reflex or anesthesia dolorosa (Table 1) . Although weakness was noted in 14%, hypesthesia in 23%, and dysesthesias in 14%, these were minor in all instances and tended to improve from 3 to 12 months after PTGC. Five patients described numbness which could not be detected on neurological examination. None of the patients experienced profound weakness, hypesthesia, or dysesthesias. One patient suffered a sixth nerve palsy for 3 days. Another patient experienced headache and aseptic meningitis which resolved. Otalgia ("popping in the ears") was experienced by three patients for 1 week following PTGC. One of these had a hemotympanum, but no pathology was detected in the other two.
The balloon inflation pressure was measured during PTGC in six patients when the balloon was inflated to obtain a radiographic "pear shape." In these six patients, the mean in vivo intraluminal pressure in the No. 4 Fogarty catheter (_ standard deviation) was 999 _ 166 mm Hg (range 459 to 1273 mm Hg). The mean in vitro intraluminal pressure was 500 + 30 mm Hg in eight patients when the balloon was inflated to a volume of 0.75 cc. The mean pressure of tissue compression was thus 499 mm Hg.
The balloon inflation pressure was also measured in seven fresh cadavers. The needle and balloon were positioned under fluoroscopic guidance, similar to the technique used in patients. Mean in vivo pressure was 1266 ___ 80 mm Hg. Thus, the mean pressure of tissue compression was 766 mm Hg. Review of the balloon location in these cadavers showed that the radiographic "pear shape" occurs because of extension of the tip of the fully inflated balloon into the more slender porus trigeminus posterior to the ganglion, surrounding the sensory and motor roots.
Discussion
Modifications of the technique described by Mullan and Lichtor ~9 were made in most series (Table 2) . Except for later patients in Mullan's group and this The follow-up period, percentage recurrence, initial pain relief, and incidence of corneal anesthesia, anesthesia dolorosa, masseter/pterygoid weakness, other cranial nerve palsy, hypesthesia, and dysesthesias for each series are compared in Table 3 . The overall results of PTGC in 310 patients from published series are summarized in Table 4 . None of the published series of PTGC has a minimum follow-up period of 3 years, and the maximum follow-up period exceeded 5 years in only two series. 1,19 The recurrence rate for PTGC ranged from 4% to 55% (mean 24%). This is compa-rable to the recurrence rate after other current procedures for treatment of trigeminal neuralgia. The recurrence rate after radiofrequency rhizotomy was 21% to 28% in five large series with a minimum follow-up period of 3 to 5 yearsfl 3 Among 923 patients in four series of patients who had undergone microvascular decompression, there was a 17% to 26% recurrence rater 3 Recurrence rates for percutaneous glycerol injection range from 17% to 50%. 4'12'17 '24 One death has been reported after PTGC. 22 This occurred in a patient with cerebral atrophy. The patient had a subarachnoid hemorrhage, then developed normal-pressure hydrocephalus. This case was not reported as part of a larger series.
Hemorrhage may occur in several ways during PTGC. An accessory meningeal artery which traverses the foramen ovale may be injured. 28 This artery may arise from the maxillary or middle meningeal artery. The bone roof of the carotid canal beneath the trigeminal ganglion may be replaced by a thin layer of connective tissue. 14 The carotid artery may then be injured by inflation of the balloon catheter. Taren and Kahn 26 often noted blood in the middle ear after an extradural approach for trigeminal rhizotomy. They believed the bleeding arose from division of perforating vessels from the dura which enter the middle ear from the tegmen tympanum; these may be torn during elevation of the dura (one patient in this series had a postoperative hemotympanum). During PTGC, hemorrhage may occur due to injury of small ganglionic branches of the middle meningeal artery which supply the trigeminal ganglion and root. 28 Anesthesia dolorosa after PTGC has not been reported. Only one patient has had corneal anesthesia. 8 Cadaver studies of balloon position showed that, because the needle and catheter enter the middle fossa through the foramen ovale, balloon position was adjacent to the inferolateral fibers of the ganglion. The superomedial fibers, largely from the ophthalmic nerve, are least compressed by the balloon, so corneal fiber injury is less likely.
Mild to moderate hypesthesia was present in 43% of the 310 patients reported. Only 1% of cases suffered 
severe hypesthesia; mild to moderate dysesthesias were present in 7%, and severe dysesthesias occurred in 4%. Masseter or pterygoid muscle weakness was present in 18%. Dysesthesia was defined in this series as the occasional presence of burning, crawling, or other "odd" sensations on the side of compression. Except in one patient with dysesthesias remaining from a previous destructive procedure, these dysesthesias were minimal and only mentioned in passing by the patient when questioned about their presence. Mullan and Lichtor 19 recommended microvascular decompression in younger patients with trigeminal neuralgia because of the occurrence of dysesthesias with PTGC. In his early patients, Mullan compressed the ganglion for up to 7 minutes) 9 This longer duration of compression may explain the 6% severe dysesthesia rate which he observed in his series of 72 patients. The auditory complaints (otalgia) may be due to mandibular nerve injury causing paresis of the tensor veli palatini and tensor tympani muscles. The mandibular nerve innervates the tensor veli palatini and the tensor tympani fibers that pass through the otic ganglion. Otalgia has also occurred after radiofrequency rhizotomy, z7
There are significant autonomic changes during PTGC. Mullan and Lichtor, ~9 Belbar and Rak,' and Spaziante, et al., 22 have each observed bradycardia of brief duration during the procedure. Brown and Preul 3 have described significant abrupt drops in heart rate and blood pressure during placement of the needle at the foramen ovale, catheter advancement, or balloon inflation. Bradycardia was present in 70% and hypotension in 55% of patients. These findings demonstrated for the first time a trigeminal depressor response in humans.3.J5 Because both bradycardia and hypotension may lead to hypoperfusion and cerebral or myocardial infarction, there is benefit from blocking the depressor response. Continuous arterial pressure and heart rate monitoring should be conducted during PTGC; how- ever, the trigeminal depressor response is an accurate physiological marker of correct needle and catheter location. Detection of bradycardia of rapid onset reduces the risk of advancing the No. 14 needle intracranially. Atropine pretreatment will block this response and has been suggested. 2 The external pacemaker, however, responds immediately to raise the heart rate to a specified pace. This technique may avoid the tachycardia and ventricular arrhythmias that occur with atropine infusion because of the manageability of its response, yet will allow detection of the onset of the bradycardia. Atropine should be immediately available for intravenous infusion if an external pacemaker is not used. Neurophysiological assessment of trigeminal function after surgery for trigeminal neuralgia has been performed by Cruccu, et al. 6 They studied the early and late blink reflexes, early and late masseter silent periods, and the jaw jerk in normal individuals and 35 patients after PTGC or radiofrequency rhizotomy. Corneal reflex was most sensitive to radiofrequency injury, and the jaw jerk was most sensitive to injury by PTGC. The other trigeminal reflexes showed intermediate injury depending on afferent fiber size. Radiofrequency rhizotomy is thought to be successful because blockade of A-delta and C fibers occurs at lower temperatures than for A-beta fiber transmission. ~~ Cruccu, et al., noted, however, that radiofrequency rhizotomy caused a severe sensory impairment in all afferent types, with slow recovery if any. They observed anesthesia and a stable motor fiber impairment after radiofrequency rhizotomy. Percutaneous microcompression also caused trigeminal dysfunction; however, significant improvement took place after 2 to 12 months.
It is concluded from this study that PTGC has a low risk of causing severe hypesthesia, and is associated with a low incidence of corneal reflex impairment. The PTGC procedure does not cause intraoperative patient discomfort and is technically simple to perform.
